A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study)
Prabhat Kumar Agrawal, Ketan K Mehta, Abhisekh Raha, Rajesh Agarwal et autres
in, us (code pays fourni par la source)
2 citations
Journal of the Association of Physicians of India